| M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors YW Choo, M Kang, HY Kim, J Han, S Kang, JR Lee, GJ Jeong, SP Kwon, ... ACS nano 12 (9), 8977-8993, 2018 | 315 | 2018 |
| T‐cell‐mimicking nanoparticles for cancer immunotherapy M Kang, J Hong, M Jung, SP Kwon, SY Song, HY Kim, JR Lee, S Kang, ... Advanced Materials 32 (39), 2003368, 2020 | 85 | 2020 |
| Immunomodulatory lipocomplex functionalized with photosensitizer-embedded cancer cell membrane inhibits tumor growth and metastasis HY Kim, M Kang, YW Choo, S Go, SP Kwon, SY Song, HS Sohn, J Hong, ... Nano Letters 19 (8), 5185-5193, 2019 | 80 | 2019 |
| Nanocomplex‐mediated in vivo programming to chimeric antigen receptor‐M1 macrophages for cancer therapy M Kang, SH Lee, M Kwon, J Byun, D Kim, C Kim, S Koo, SP Kwon, ... Advanced materials 33 (43), 2103258, 2021 | 79 | 2021 |
| T‐cell‐derived nanovesicles for cancer immunotherapy J Hong, M Kang, M Jung, YY Lee, Y Cho, C Kim, SY Song, CG Park, ... Advanced Materials 33 (33), 2101110, 2021 | 44 | 2021 |
| Interleukin‐4 gene transfection and spheroid formation potentiate therapeutic efficacy of mesenchymal stem cells for osteoarthritis SY Song, J Hong, S Go, S Lim, HS Sohn, M Kang, GJ Jung, JK Yoon, ... Advanced Healthcare Materials 9 (5), 1901612, 2020 | 33 | 2020 |
| Nanovesicle‐mediated targeted delivery of immune checkpoint blockades to potentiate therapeutic efficacy and prevent side effects M Jung, M Kang, BS Kim, J Hong, C Kim, CH Koh, G Choi, Y Chung, ... Advanced Materials 34 (9), 2106516, 2022 | 27 | 2022 |
| A Therapeutic Nanovaccine that Generates Anti‐Amyloid Antibodies and Amyloid‐specific Regulatory T Cells for Alzheimer's Disease M Jung, S Lee, S Park, J Hong, C Kim, I Cho, HS Sohn, K Kim, IW Park, ... Advanced Materials 35 (3), 2207719, 2023 | 18 | 2023 |
| Cardiac-mimetic cell-culture system for direct cardiac reprogramming SY Song, J Yoo, S Go, J Hong, HS Sohn, JR Lee, M Kang, GJ Jeong, ... Theranostics 9 (23), 6734, 2019 | 18 | 2019 |
| Regulatory T cell-mediated tissue repair J Hong, BS Kim Biomimetic Medical Materials: From Nanotechnology to 3D Bioprinting, 221-233, 2018 | 16 | 2018 |
| Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine J Hong, M Jung, C Kim, M Kang, S Go, H Sohn, S Moon, S Kwon, ... Experimental & Molecular Medicine 55 (3), 541-554, 2023 | 8 | 2023 |
| A senolytic-eluting coronary stent for the prevention of in-stent restenosis C Kim, SG Lee, S Lim, M Jung, SP Kwon, J Hong, M Kang, HS Sohn, S Go, ... ACS Biomaterials Science & Engineering 8 (5), 1921-1929, 2022 | 8 | 2022 |
| Iron oxide nanoparticle-incorporated mesenchymal stem cells for Alzheimer’s disease treatment M Jung, H Kim, JW Hwang, Y Choi, M Kang, C Kim, J Hong, NK Lee, ... Nano Letters 23 (2), 476-490, 2023 | 7 | 2023 |
| Multilayered cell sheets of cardiac reprogrammed cells for the evaluation of drug cytotoxicity SP Kwon, SY Song, J Yoo, HY Kim, JR Lee, M Kang, HS Sohn, S Go, ... Tissue Engineering and Regenerative Medicine 18, 807-818, 2021 | 5 | 2021 |
| A Personalized Cancer Nanovaccine that Enhances T‐Cell Responses and Efficacy Through Dual Interactions with Dendritic Cells and T Cells S Go, M Jung, S Lee, S Moon, J Hong, C Kim, Y Chung, BS Kim Advanced Materials 35 (49), 2303979, 2023 | 4 | 2023 |
| Immunomodulation for tissue repair and regeneration S Moon, J Hong, S Go, BS Kim Tissue engineering and regenerative medicine 20 (3), 389-409, 2023 | 3 | 2023 |
| A personalized cancer vaccine that induces synergistic innate and adaptive immune responses DS Kuen, J Hong, S Lee, CH Koh, M Kwak, BS Kim, M Jung, YJ Kim, ... Advanced Materials 35 (36), 2303080, 2023 | 2 | 2023 |
Byung-Soo KimSeoul National UniversityVerified email at snu.ac.kr
